Search Within

Center for Hematologic Malignancies

Formats
  1. Journal Article (6192)
  2. Meeting Abstract (6164)
  3. Review (400)
  4. Book Section (216)
  5. Editorial (172)
  6. Research Letter (159)
  7. Guidelines (83)
  8. Conference Paper (70)
  9. Correspondence (61)
  10. Miscellaneous (19)
  11. Book Whole (10)
Groups
  1. Department of Medicine (11088)
  2. Hematologic Malignancies, Division of (10639)
  3. GSK Faculty (5447)
  4. Adult Leukemia (3722)
  5. Sloan Kettering Institute Faculty (3375)
  6. Hematologic Malignancies Research (3005)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (944)
  3. Ross Levine (787)
  4. Andrew Zelenetz (785)
  5. Steven Horwitz (671)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (310)
  2. 2024 (704)
  3. 2023 (877)
  4. 2022 (830)
  5. 2021 (802)
  6. 2020 (874)

More Years

Publications
  1. Blood (3413)
  2. Journal of Clinical Oncology (869)
  3. Biology of Blood and Marrow Transplantation (602)
  4. Clinical Lymphoma, Myeloma and Leukemia (304)
  5. Cancer Research (300)
  6. Haematologica (267)

More Publications

Publishers
  1. American Society of Hematology (3684)
  2. Elsevier Inc. (1668)
  3. Nature Publishing Group (1117)
  4. American Society of Clinical Oncology (918)
  5. American Association for Cancer Research (680)
  6. Wiley Blackwell (437)

More Publishers

Results (13546)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Pre-transplant evaluation with both CT and PET following second-line therapy is essential for predicting outcome in patients with transplant-eligible relapsed and primary refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Nimer, S. D.; Zelenetz, A. D.; Kewalramani, T.; Vanak, J. M.; Maragulia, J. C.; Yahalom, J.; Moskowitz, C.
    Blood (2008)

    Fulltext@MSK | Save
  • OTT-MAL activates the Notch signaling transcription factor RBPJ and cooperates with mutant MPL to induce acute megakaryoblastic leukemia
    Meeting Abstract

    Mercher, T.; Raffel, G. D.; Moore, S. A.; Cornejo, M. G.; Baudry-Bluteau, D.; Cagnard, N.; Jesneck, J.; Pikman, Y.; Cullen, D. E.; Williams, I.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Rituximab fails to reduce histologic transformation (HT) rate of follicular lymphoma (FL) to diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Marciscano, A. E.; Gupta, N.; Zhang, Z. G.; Teruya-Feldstein, J.; Noy, A.
    Blood (2008)

    Fulltext@MSK | Save
  • Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine in recipients of related and unrelated allogeneic hematopoietic cell transplants (HCT)
    Meeting Abstract

    Mahler, M.; Kernan, N. A.; Boulad, F.; Prockop, S.; Scaradavou, A.; Papadopoulos, E. B.; Abendroth, H.; Casson, A.; Copeland, C.; Murphy, M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Fine needle aspiration of salivary duct carcinoma: A morphologic spectrum
    Meeting Abstract

    Macias, A.; Ghossein, R.; Lin, O.
    Cancer Cytopathology (2008)

    Fulltext@MSK | Save
  • Antitumor efficacy of the purine-scaffold Hsp90 inhibitor PU-H71 in diffuse large-B cell lymphoma
    Meeting Abstract

    Lopes, E. C.; Cerchietti, L.; Yang, S. N.; Melnick, A.; Chiosis, G.
    Blood (2008)

    Fulltext@MSK | Save
  • Optimization of the beta-globin LCR and promoter elements for lentiviral vector-encoded the beta-globin transgene expression in beta-thalassemic mice
    Meeting Abstract

    Lisowski, L.; Sadelain, M.
    Blood Cells, Molecules, and Diseases (2008)

    Fulltext@MSK | Save